Motion Sickness clinical trials
The registry lists 48 studies for Motion Sickness across more than 10 countries. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-10.
Status
- Completed
- 29
- Recruiting
- 5
- Status unknown
- 5
- Not yet recruiting
- 2
- Active, not recruiting
- 2
- Terminated
- 2
Phase
- Phase 3
- 11
- Phase 2
- 8
- Phase 4
- 5
- Phase 1
- 2
Where
- United States
- 27
- China
- 4
- France
- 2
- Israel
- 2
- Turkey (Türkiye)
- 2
- Pakistan
- 2
Who runs them
Repurposed Therapeutics, Inc. (9) · Vanda Pharmaceuticals (4) · Medical Corps, Israel Defense Force (4) · Abant Izzet Baysal University (2) · University of Wisconsin, Madison (2) · Mayo Clinic (2) · University Hospital, Caen (2) · Naval Aeromedical Research Unit, Dayton (1)
Studies
Recruiting first, then most recently updated. Showing 48 of 48 — search for more.
- StableEyes With Active NeurofeedbackRecruitingNCT05622344Not applicable1 country
- Motion Sickness Severity and Sensorimotor PerformanceNot yet recruitingNCT07619469
- OKT With Gaze and Postural Stabilization on Vertigo, MS and QOL in VBHNot yet recruitingNCT07575074Not applicable1 country
- Virtual Reality Sickness Questionnaire: Psychometrics in Stroke PatientsEnrolling by invitationNCT072978621 country
- Optokinetic Virtual Reality Stimulation in Unilateral Vestibular HypofunctionRecruitingNCT06517446Not applicable1 country
- Evaluation of a Device to Reduce Motion Sickness and Spatial DisorientationRecruitingNCT06892340Not applicable1 country
- Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor PerformanceRecruitingNCT05886660Phase 21 country
- Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor PerformanceRecruitingNCT05852730Phase 21 country
- Gaze Stabilization vs Oculomotor Exercises on Cybersickness in Computer UsersCompletedNCT07616596Not applicable1 country
- Prevention of Post-Operative Nausea and Vomiting With Propofol InfusionCompletedNCT05759481Phase 21 country
- Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion SicknessActive, not recruitingNCT06138613Phase 31 country
- Three-Axis Wearable Adaptive Vestibular StimulatorActive, not recruitingNCT06106256Not applicable1 country
- The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor FunctionCompletedNCT06587386Phase 41 country
- Nebulizer Delivery of Intranasal ScopolamineCompletedNCT04999449Phase 11 country
- Impact of Different Types of Virtual Reality Games on Motion Sickness and Ocular in Adults: A Pilot StudyCompletedNCT06354309Not applicable1 country
- Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion SicknessCompletedNCT03772340Phase 21 country
- Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular SchwannomaWithdrawnNCT04196933Not applicable1 country
- Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion SicknessCompletedNCT05903924Phase 31 country
- Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion SicknessCompletedNCT04327661Phase 31 country
- Vestibulo-Ocular Reflex Function in Individuals With Chronic Motion Sensitivity Cross-Sectional StudyCompletedNCT061287071 country
- Gynecologic Endoscopic Surgery of Female Motion Sickness PatientsCompletedNCT06232785Phase 41 country
- Non-pharmaceutical Motion Sickness MitigationCompletedNCT04859868Not applicable1 country
- Motion Sickness Rehabilitation for Virtual RealityCompletedNCT06056622Not applicable1 country
- Sensory Training for Visual Motion SicknessCompletedNCT04420949Not applicable1 country
- Prevention and Treatment of Nausea Associated With Motion Sickness in Senior SubjectsCompletedNCT03988530Phase 31 country
- Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With MotionCompletedNCT05548270Phase 31 country
- Video Head Impulse Test and Seasickness SusceptibilityCompletedNCT05657340Not applicable1 country
- Seasickness Susceptability and Vestibular Time ConstantCompletedNCT05640258Not applicable1 country
- Motion Sickness Desensitization Using VRStatus unknownNCT05628220Not applicable1 country
- Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness SymptomsCompletedNCT05611814Not applicable1 country
- Sensory Training for Orientation and BalanceWithdrawnNCT04331561Not applicable1 country
- Motion Sickness on Astrolabe's VesselCompletedNCT029114021 country
- Nasal Gel for the Prevention of Nausea and Vomiting Associated With MotionCompletedNCT04947423Phase 31 country
- Galvanic Vestibular Stimulation as a Novel Treatment for SeasicknessCompletedNCT05004818Not applicable
- Meclizine Plasma Levels in Responders and Non-respondersStatus unknownNCT04482985Phase 4
- Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion SicknessStatus unknownNCT04272255Phase 31 country
- DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion SicknessTerminatedNCT04219982Phase 2/31 country
- Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion SicknessCompletedNCT04184115Phase 31 country
- Clinical Evaluation of the Use of Ginger Extract in the Management of Motion SicknessCompletedNCT03755596Phase 41 country
- Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going VesselsStatus unknownNCT03920644Phase 31 country
- A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.CompletedNCT02839135Phase 11 country
- Pharmacokinetic and Efficacy Profile Intranasal Scopolamine SprayTerminatedNCT02155309Phase 2/31 country
- Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity LevelsCompletedNCT02136420Phase 41 country
- Research on Quantification of VR(Virtual Reality) Related Stress and RelaxationStatus unknownNCT02986555Not applicable1 country
- Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy VolunteersCompletedNCT02177890Not applicable1 country
- Levo Phencynonate Hydrochloride for the Prevention of SeasicknessCompletedNCT02241629Phase 21 country
- Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?CompletedNCT00360282Not applicable1 country
- Effects of Transdermal Scopolamine on Occupational PerformanceCompletedNCT00374478Phase 21 country